Join Tom Parke to learn more about using clinical trial simulations and calculations of expected net present value (eNPV) to optimise development decisions and trial designs. Two examples of simulating and optimising drug development plans are presented — 1. DIA Adaptive Program (Oncology sub-stream), looking at the problem of how best to develop two candidate [...]
In the not-so-distant future, the pharmaceutical industry will need to move away from serendipity and its “blockbuster” drug development approach to become a service-based business specializing in patient-specific therapeutics delivering desired outcomes at the desired price. Clinical trials, of necessity, will be re-engineered to reflect real-world circumstances and turn adaptive study programs into a competitive [...]
Pharmaceutical Product Development (PPD) has entered into a license agreement to use Tessella and Berry Consultants’ adaptive trial design solution…read more
You are invited to join Tom Parke to learn more about using clinical trial simulations and calculations of expected net present value (eNPV) to optimise development decisions and trial designs. Abstract: Two examples of simulating and optimising drug development plans will be presented – 1. DIA Adaptive Program (Oncology sub-stream), looking at the problem of [...]
FACTSTM software enhances PPD’s ability to deliver time- and cost-savings for clients WILMINGTON, N.C., and NEWTON, Mass. (November 14, 2012) – Pharmaceutical Product Development, LLC (PPD) has signed a license agreement to use Tessella and Berry Consultants’ FACTSTM software to create a more flexible, intuitive approach for designing both adaptive and fixed trials. The software [...]
Novel work analysing microneurography data wins Tessella Excellence Award A Tessella project, working with a team of Neusentis scientists from Cambridge and other Pfizer scientists from Sandwich, respectively, has been recognised for novel work analysing microneurography data with a Tessella Excellence Award in the ‘Most Innovative Work’ category. The Tessella Excellence Awards were created to [...]
Aptiv Solutions, Berry Consultants and Tessella have partnered together to develop a one day forum to address the challenges in adopting adaptive trials in the drug, medical device and clinical research industry and assess their potential for transforming drug development. Join experts in the economics and management of the pharmaceutical industry, drug developers, and adaptive [...]
Kert Viele describes how simulation can help you overcome the challenges of designing enrichment studies in personalized medicine Oxford, UK | 17th September 2012. Tessella, the international provider of science powered technology and consulting services, is hosting a free online webinar, first of an Autumn series, for all life sciences professionals interested in deepening their [...]
Watch on youtube In this webinar Tom Parke discusses key questions about the use of quantitative decision making in drug development through simulation including: How can simulations of drug response be used to design a trial? With so many issues, including sub-population analysis, comparative effectiveness and testing drugs in combination, how can you decide what [...]
Aptiv Solutions, a global biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today a collaboration with Tessella, a world leader in the provision of science powered technology and consulting services and Berry Consultants, leaders in the Bayesian approach to medical statistics, to deliver integrated early [...]
